Clinical Study on Pentongling Decoction Rectal administration in Treating Chronic Pelvic Pain

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ITMCTR

Registry ID

ITMCTR2000003634

Enrollment

Unknown

Registered

2020-08-22

Start date

2020-10-01

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pelvic pain

Interventions

Pentongling rectal administration treatment group:Pentongling rectal administration

Chinese medicine placebo control group:Chinese medicine placebo rectal administration

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 to 55 years old, meet the diagnostic criteria for chronic pelvic pain (gynecological etiology); 2. VAS score <= 6; 3. Those who agree to participate in this research.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardio-cerebrovascular, liver, kidney and hematopoietic system and other primary diseases; 2. Patients with malignant tumor disease; 3. Mentally ill, breastfeeding, menopausal women, and those who are preparing for pregnancy; 4. Persons who have used hormone drugs in the past month; 5. Those with hemorrhoids.

Design outcomes

Primary

Measure	Time frame
Hamilton Depression Scale;Syndrome Score Table;Hamilton Anxiety Scale;Quality of life scale;Physical Sign Score Table;VAS score;	—

Secondary

Measure	Time frame
Gynecology B ultrasound;Hemorheology;Prostaglandin F2a;	—

Countries

China

Contacts

Public ContactFu Jinrong

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

fujinrong2006@sina.com+86 18017113200

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026